Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:jhw1

Total Results:

290


Strategies for the surgical management of pediatric optic pathway gliomas-experience with 100 patients [Meeting Abstract]

Teresa, Hidalgo E; Kvint, S; Thomas, C; Orrilac, C; North, E; Dastagirzada, Y; Snuderl, M; Wisoff, J H
Introduction: Pediatric optic pathway gliomas (OPGs) are often considered benign, but can have detrimental effects on the quality of life, impair vision and are a potentially lethal disease. The aim of this study is to report the characteristics and outcomes of surgically treated pediatric OPGs and to identify candidates for different treatment strategies. Methods: Retrospective chart review of consecutive pediatric patients with surgically treated OPGs by a single surgeon at our institution from 1985-2015. Three treatment pathways were defined: (1) surgery without planned adjuvant therapy; (2) surgery with planned adjuvant therapy; and, (3) patients with prior treatment.Results: 100 patients-55 male and 45 female-were included in analysis. 8 patients had NF1. Pathology revealed pilocytic astrocytoma (45%), pilomyxoid astrocytoma (9%), ganglioglioma (3%), and unknown (35%). Radiologic location of the tumor was: hypothalamic 86%, involvement of only chiasm and/or tract in 12%. Median age at diagnosis was 4 years, median age at surgery was 6 years, and median time from diagnosis to surgery was 1 year. Pathway 1: 39 patients; median PFS 73+17 months; OS rate 74%; median follow-up 117 months. Pathway 2: 10 patients; median PFS 29+15 months; OS rate 70%; median follow-up 59 months. Pathway 3: 51 patients; median PFS 33+8 months; OS rate 80%; median follow-up was 73 months. Conclusion: The role of surgery in the treatment of pediatric OPGs depends on patient characteristics and tumor biology. With the adequate therapeutic strategy, long-term PFS and OS can be achieved
EMBASE:611934154
ISSN: 1523-5866
CID: 2258952

Endothelium-independent primitive myxoid vascularization creates invertebrate-like channels to maintain blood supply in optic gliomas [Meeting Abstract]

Snuderl, M; Zhang, G; Wu, P; Jennings, T; Shroff, S; Ortenzi, V; Jain, R; Cohen, B; Reidy, J; Dushay, M; Wisoff, J; Harter, D; Karajannis, M; Fenyo, D; Neubert, T; Zagzag, D
INTRODUCTION: Optic gliomas are classified as pilocytic astrocytoma (PA) or pilomyxoid astrocytoma (PMXA). Abundant bluish chondroid myxoid matrix is characteristic of PMXA but not PA. We sought to investigate the molecular composition of myxoid matrix and its biologic role in angiogenesis of optic gliomas. We reviewed clinical and pathological data on a cohort of 120 patients with optic glioma diagnosed at NYU Langone Medical Center from 1996 to 2014. We analyzed microvascular density (MVD), perfusion, hypoxia and proliferation by immunohistochemistry and ultrastructural features by electron microscopy. To identify the composition of the myxoid matrix in PMXA we performed liquid chromatography-mass spectrometry (LC-MS) without sample fractionation quantified using peptide spectral counts. PMXA showed significantly lower MVD by CD34 (8.1 vs 14.5, p-value < 0.002) and Erg (7 vs. 13.6, p-value 0.003) than PA, however GLUT-1 showed equal perfusion. Electron microscopy showed that PMXA contain both regular blood vessels with endothelial lining and channels completely lacking endothelial and smooth muscle cells. LC-MS stratified optic gliomas into three distinct groups. We identified 5389 proteins of which 188 were differentially expressed in the three groups (p<0.05, Benjamini-Hochberg adjustment). Between PA and PMXA, we found that most of differentially expressed proteins (146/188) displayed a positive fold change (increasing in PMXA relative to PA), and a minority (42/188) showed a negative fold change. The most abundant extracellular matrix proteins were a chondroitin sulfate proteoglycan versican (VCAN 3.7-fold increase Q=0.000463) and its paralog vertebrate Hyaluronan And Proteoglycan Link Protein 1 (HAPLN1, 22-fold increase from the PA to the PMXA group Q=4.60x10-7). Optic gliomas can develop endothelium-independent channels reminiscent of those in invertebrates to maintain blood supply. The myxoid matrix is composed of VCAN and its linking paralog HAPLN1. Targeting the myxoid matrix may provide novel avenues for therapy of optic gliom
EMBASE:622711609
ISSN: 1554-6578
CID: 3188352

Divergent clonal selection dominates medulloblastoma at recurrence

Morrissy, A Sorana; Garzia, Livia; Shih, David J H; Zuyderduyn, Scott; Huang, Xi; Skowron, Patryk; Remke, Marc; Cavalli, Florence M G; Ramaswamy, Vijay; Lindsay, Patricia E; Jelveh, Salomeh; Donovan, Laura K; Wang, Xin; Luu, Betty; Zayne, Kory; Li, Yisu; Mayoh, Chelsea; Thiessen, Nina; Mercier, Eloi; Mungall, Karen L; Ma, Yusanne; Tse, Kane; Zeng, Thomas; Shumansky, Karey; Roth, Andrew J L; Shah, Sohrab; Farooq, Hamza; Kijima, Noriyuki; Holgado, Borja L; Lee, John J Y; Matan-Lithwick, Stuart; Liu, Jessica; Mack, Stephen C; Manno, Alex; Michealraj, K A; Nor, Carolina; Peacock, John; Qin, Lei; Reimand, Juri; Rolider, Adi; Thompson, Yuan Y; Wu, Xiaochong; Pugh, Trevor; Ally, Adrian; Bilenky, Mikhail; Butterfield, Yaron S N; Carlsen, Rebecca; Cheng, Young; Chuah, Eric; Corbett, Richard D; Dhalla, Noreen; He, An; Lee, Darlene; Li, Haiyan I; Long, William; Mayo, Michael; Plettner, Patrick; Qian, Jenny Q; Schein, Jacqueline E; Tam, Angela; Wong, Tina; Birol, Inanc; Zhao, Yongjun; Faria, Claudia C; Pimentel, Jose; Nunes, Sofia; Shalaby, Tarek; Grotzer, Michael; Pollack, Ian F; Hamilton, Ronald L; Li, Xiao-Nan; Bendel, Anne E; Fults, Daniel W; Walter, Andrew W; Kumabe, Toshihiro; Tominaga, Teiji; Collins, V Peter; Cho, Yoon-Jae; Hoffman, Caitlin; Lyden, David; Wisoff, Jeffrey H; Garvin, James H; Stearns, Duncan S; Massimi, Luca; Schuller, Ulrich; Sterba, Jaroslav; Zitterbart, Karel; Puget, Stephanie; Ayrault, Olivier; Dunn, Sandra E; Tirapelli, Daniela P C; Carlotti, Carlos G; Wheeler, Helen; Hallahan, Andrew R; Ingram, Wendy; MacDonald, Tobey J; Olson, Jeffrey J; Van Meir, Erwin G; Lee, Ji-Yeoun; Wang, Kyu-Chang; Kim, Seung-Ki; Cho, Byung-Kyu; Pietsch, Torsten; Fleischhack, Gudrun; Tippelt, Stephan; Ra, Young Shin; Bailey, Simon; Lindsey, Janet C; Clifford, Steven C; Eberhart, Charles G; Cooper, Michael K; Packer, Roger J; Massimino, Maura; Garre, Maria Luisa; Bartels, Ute; Tabori, Uri; Hawkins, Cynthia E; Dirks, Peter; Bouffet, Eric; Rutka, James T; Wechsler-Reya, Robert J; Weiss, William A; Collier, Lara S; Dupuy, Adam J; Korshunov, Andrey; Jones, David T W; Kool, Marcel; Northcott, Paul A; Pfister, Stefan M; Largaespada, David A; Mungall, Andrew J; Moore, Richard A; Jabado, Nada; Bader, Gary D; Jones, Steven J M; Malkin, David; Marra, Marco A; Taylor, Michael D
The development of targeted anti-cancer therapies through the study of cancer genomes is intended to increase survival rates and decrease treatment-related toxicity. We treated a transposon-driven, functional genomic mouse model of medulloblastoma with 'humanized' in vivo therapy (microneurosurgical tumour resection followed by multi-fractionated, image-guided radiotherapy). Genetic events in recurrent murine medulloblastoma exhibit a very poor overlap with those in matched murine diagnostic samples (<5%). Whole-genome sequencing of 33 pairs of human diagnostic and post-therapy medulloblastomas demonstrated substantial genetic divergence of the dominant clone after therapy (<12% diagnostic events were retained at recurrence). In both mice and humans, the dominant clone at recurrence arose through clonal selection of a pre-existing minor clone present at diagnosis. Targeted therapy is unlikely to be effective in the absence of the target, therefore our results offer a simple, proximal, and remediable explanation for the failure of prior clinical trials of targeted therapy.
PMCID:4936195
PMID: 26760213
ISSN: 1476-4687
CID: 1912632

BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology

Shankar, Ganesh M; Lelic, Nina; Gill, Corey M; Thorner, Aaron R; Van Hummelen, Paul; Wisoff, Jeffrey H; Loeffler, Jay S; Brastianos, Priscilla K; Shin, John H; Borges, Lawrence F; Butler, William E; Zagzag, David; Brody, Rachel I; Duhaime, Ann-Christine; Taylor, Michael D; Hawkins, Cynthia E; Louis, David N; Cahill, Daniel P; Curry, William T; Meyerson, Matthew
PMCID:4698284
PMID: 26487540
ISSN: 1432-0533
CID: 1810512

ACTA NEUROPATHOLOGICA COMMUNICATIONS [Letter]

Orillac, Cordelia; Thomas, Cheddhi; Dastagirzada, Yosef; Hidalgo, Eveline Teresa; Golfinos, John G.; Zagzag, David; Wisoff, Jeffrey H.; Karajannis, Matthias A.; Snuderl, Matija
ISI:000381339100002
ISSN: 2051-5960
CID: 5883592

Endoscopic resection of solid intraventricular tumors in children [Meeting Abstract]

Hidalgo, E T; Ali, A; Wisoff, J H; Weiner, H L; Harter, D H
Objective: We report the feasibility and outcomes of endoscopic resection of select intraventricular tumors in children. Methods: The clinical characteristics of 11 children with solid intraventricular tumors who underwent tumor resection were reviewed. 12 procedures were performed. Results: Gross total resection was achieved in 11 of 12 cases (92%). Maximal diameter ranged from 9-26 mm (mean 16.6 mm). Pathology included subependymal giant cell astrocytomas (SEGA), ependymomas, non-germinomatous germ cell tumor (NGGCT) and pilocytic astrocytoma. Mean follow-up was 35 months (range 10-109 months). All patients returned to their neurological baseline following surgery. Local tumor recurrence occurred in one patient and distant recurrence in another. Complications occurred in one patient, no permanent morbidity or mortality occurred. Hydrocephalus was present preoperatively in 5 cases and was treated with tumor removal alone or with additional endoscopic third ventriculostomy. No patient required a ventriculoperitoneal shunt. Conclusion: Neuroendoscopic gross-total resection of solid intraventricular tumors is a safe procedure in carefully selected pediatric patients
EMBASE:72187571
ISSN: 0256-7040
CID: 1950582

NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA [Meeting Abstract]

Snuderl, Matija; Kannan, Kasthuri; Aminova, Olga; Dolgalev, Igor; Heguy, Adriana; Faustin, Arline; Zagzag, David; Gardner, Sharon; Allen, Jeffrey; Wisoff, Jeffrey; Capper, David; Hovestadt, Volker; Ahsan, Sama; Eberhart, Charles; Pfister, Stefan; Jones, David; Karajannis, Matthias
ISI:000361304800094
ISSN: 1523-5866
CID: 2687502

EFFECTS OF EVEROLIMUS ON MENINGIOMA GROWTH IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2 [Meeting Abstract]

Osorio, Diana; Filatov, Alexander; Hagiwara, Mari; Mitchell, Carole; Wisoff, Jeffrey; Golfinos, John; Roland, J. Thomas; Allen, Jeffrey; Karajannis, Matthias
ISI:000361304800159
ISSN: 1522-8517
CID: 2964282

Novel Candidate Oncogenic Drivers in Pineoblastoma [Meeting Abstract]

Snuderl, Matija; Kannan, Kasthuri; Aminova, Olga; Dolgalev, Igor; Heguy, Adriana; Faustin, Arline; Zagzag, David; Gardner, Sharon; Allen, Jeffrey; Wisoff, Jeffrey; Capper, David; Hovestadt, Volker; Ahsan, Sama; Eberhart, Charles; Pfister, Stefan; Jones, David; Karajannis, Matthias
ISI:000354824800135
ISSN: 0022-3069
CID: 1620172

Biopsy-Proven Spontaneous Regression of a Rhabdomyomatous Mesenchymal Hamartoma

Mazza, Joni M; Linnell, Erica; Votava, Henry J; Wisoff, Jeffrey H; Silverberg, Nanette B
Rhabdomyomatous mesenchymal hamartoma (RMH) is a rare, benign, congenital tumor of the dermis and subcutaneous tissue comprised of skeletal muscle and adipose and adnexal elements. Although the majority of cases are an incidental finding in otherwise healthy patients, some have been reported in association with other anomalies. We present a full-term boy evaluated on day 2 of life for two lesions located on the midline of the lower back and right buttock that each appeared clinically as an atrophic, pink plaque. Ultrasound of the midline lesion revealed an underlying lipomyelomeningocele with a tethered cord in the spinal canal. Histopathology of the right buttock cutaneous lesion was consistent with a diagnosis of RMH. Surgical excision was performed on the midline intradural lipoma and the lesion on the buttock was monitored clinically. Repeat biopsy of this site at 1 year of age revealed complete spontaneous regression. This case highlights three interesting features: the association with an occult spinal dysraphism lipomyelomeningocele and tethered cord, the clinical presentation of an atrophic plaque as opposed to the more commonly reported raised lesions, and the phenomenon of spontaneous regression of the lesion. Most importantly, this final feature of regression in our patient suggests that, in the absence of symptoms, clinical observation of RMH lesions is warranted for spontaneous regression for 1 to 2 years provided that no functional deficit is noted and that the cutaneous or deeper lesions are not causing a medical problem.
PMID: 24661237
ISSN: 0736-8046
CID: 933262